mmews

Briefing Explore Saved

Loading the story briefing.

mmews

Briefing Explore Saved

Loading the story briefing.

← Briefing

HealthNeutral

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Aug 19, 8:39 PM4 sources4 articlesMultiple anglesSettling in

Sources

Compare who has reported and how much of this timeline each source contributes.

The New York Times1 report

CNBC1 report

Al Jazeera1 report

Last update

Aug 19, 8:39 PM

Published

Aug 19, 8:39 PM

Representative source

Open source article →

Coverage Timeline

Showing 4 English articles

CNBCAug 19, 10:49 AMFirst report

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

The New York TimesAug 19, 3:37 PM

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.

← Briefing

HealthNeutral

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Aug 19, 8:39 PM4 sources4 articlesMultiple anglesSettling in

Sources

Compare who has reported and how much of this timeline each source contributes.

The New York Times1 report

CNBC1 report

Al Jazeera1 report

Last update

Aug 19, 8:39 PM

Published

Aug 19, 8:39 PM

Representative source

Open source article →

Coverage Timeline

Showing 4 English articles

CNBCAug 19, 10:49 AMFirst report

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

The New York TimesAug 19, 3:37 PM

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.

Ars TechnicaAug 19, 4:53 PM

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer's return and spread.

Al JazeeraAug 19, 8:39 PMLatest update

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.

Ars TechnicaAug 19, 4:53 PM

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer's return and spread.

Al JazeeraAug 19, 8:39 PMLatest update

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.